Careers Contact Us
Facebook Twitter LinkedIn
logo_abeona_retina
  • Home
  • About
    • Mission
    • Leaders
  • Science
    • Pipeline
    • Manufacturing
    • The AIMTM Vector
  • Clinical Trials
    • Overview
    • Recessive Dystrophic Epidermolysis Bullosa (RDEB)
    • Sanfilippo syndrome type A (MPS IIIA)
    • Sanfilippo syndrome type B (MPS IIIB)
  • Patients & Families
    • Patient Advocacy & Community Engagement (PACE)
    • Our Focus
    • Resources
    • Our Inspiration
    • Access Policy
  • Investors & Media
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us
×
  • Home
  • About
    • Mission
    • Leaders
  • Science
    • Pipeline
    • Manufacturing
    • The AIMTM Vector
  • Clinical Trials
    • Overview
    • Recessive Dystrophic Epidermolysis Bullosa (RDEB)
    • Sanfilippo syndrome type A (MPS IIIA)
    • Sanfilippo syndrome type B (MPS IIIB)
  • Patients & Families
    • Patient Advocacy & Community Engagement (PACE)
    • Our Focus
    • Resources
    • Our Inspiration
    • Access Policy
  • Investors & Media
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

For Patients with MPS IIIB (Sanfilippo B Syndrome)

Clinical Trials

Clinical Trials

  • Overview
  • Recessive Dystrophic Epidermolysis Bullosa (RDEB)
  • Sanfilippo syndrome type A (MPS IIIA)
  • Sanfilippo syndrome type B (MPS IIIB)

The safety and efficacy of the investigational use of this product has not been determined. There is no guarantee that the investigational use listed will be filed with and/or approved for marketing by a regulatory agency.

© 2021 Abeona Therapeutics Inc. All Rights Reserved. | Privacy Policy